IRIS
BRUNO, RAFFAELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.878
AS - Asia 8.858
EU - Europa 6.837
SA - Sud America 1.467
AF - Africa 322
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 16
AN - Antartide 1
Totale 29.402
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.566
CN - Cina 3.568
SG - Singapore 2.164
IE - Irlanda 1.305
BR - Brasile 1.123
IT - Italia 1.021
HK - Hong Kong 1.017
VN - Vietnam 1.005
RU - Federazione Russa 916
DE - Germania 789
FI - Finlandia 612
UA - Ucraina 594
FR - Francia 485
GB - Regno Unito 342
SE - Svezia 292
BD - Bangladesh 228
IN - India 228
ZA - Sudafrica 167
CA - Canada 160
AR - Argentina 120
MX - Messico 92
NL - Olanda 89
IQ - Iraq 84
TR - Turchia 78
JP - Giappone 77
PL - Polonia 67
ES - Italia 66
ID - Indonesia 57
PK - Pakistan 54
EC - Ecuador 52
BE - Belgio 48
VE - Venezuela 44
CO - Colombia 39
CZ - Repubblica Ceca 35
SA - Arabia Saudita 35
UZ - Uzbekistan 33
MA - Marocco 31
TN - Tunisia 29
AT - Austria 28
PH - Filippine 28
LT - Lituania 24
CL - Cile 23
MY - Malesia 20
IL - Israele 19
PY - Paraguay 19
AU - Australia 17
CH - Svizzera 17
AZ - Azerbaigian 16
EG - Egitto 16
JO - Giordania 16
KZ - Kazakistan 15
PE - Perù 15
AE - Emirati Arabi Uniti 14
JM - Giamaica 14
RO - Romania 14
IR - Iran 13
UY - Uruguay 13
KE - Kenya 12
ET - Etiopia 11
NP - Nepal 11
AL - Albania 10
BO - Bolivia 10
DZ - Algeria 10
EU - Europa 10
PT - Portogallo 10
BY - Bielorussia 9
KG - Kirghizistan 9
LB - Libano 9
SN - Senegal 9
MU - Mauritius 8
OM - Oman 8
PA - Panama 8
TH - Thailandia 8
CR - Costa Rica 7
GE - Georgia 7
HU - Ungheria 7
BG - Bulgaria 6
HR - Croazia 6
KR - Corea 6
LV - Lettonia 6
MD - Moldavia 6
NI - Nicaragua 6
SK - Slovacchia (Repubblica Slovacca) 6
TT - Trinidad e Tobago 6
RS - Serbia 5
AM - Armenia 4
DO - Repubblica Dominicana 4
GY - Guiana 4
HN - Honduras 4
LK - Sri Lanka 4
LY - Libia 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
SR - Suriname 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AO - Angola 3
BH - Bahrain 3
CG - Congo 3
CM - Camerun 3
DK - Danimarca 3
Totale 29.333
Salva come PNG Salva come JPEG
Città #
San Jose 1.545
Dublin 1.301
Chandler 1.254
Singapore 1.096
Ashburn 1.063
Hong Kong 985
Dallas 915
Jacksonville 725
Beijing 656
Nanjing 604
Boardman 474
Ho Chi Minh City 341
Los Angeles 341
Lauterbourg 313
New York 283
Princeton 268
Council Bluffs 242
Hanoi 240
Lawrence 235
Nanchang 235
Milan 232
Munich 230
Wilmington 219
Helsinki 216
Shenyang 193
Moscow 183
Hebei 177
Changsha 172
Medford 166
Redondo Beach 144
Johannesburg 139
Ann Arbor 137
Jiaxing 130
Shanghai 130
Buffalo 128
São Paulo 126
Turku 120
Pavia 116
Tianjin 97
Hangzhou 96
Seattle 84
Orem 79
Santa Clara 73
Tokyo 71
Frankfurt am Main 70
Da Nang 62
San Francisco 60
Chennai 57
Denver 57
Falkenstein 56
Montreal 55
Warsaw 55
Woodbridge 55
Houston 53
Brooklyn 52
Nuremberg 50
Toronto 50
Chicago 47
Norwalk 46
The Dalles 46
Brussels 45
Rome 45
Verona 43
Haiphong 41
London 39
Mexico City 37
Rio de Janeiro 37
Stockholm 36
Poplar 35
Atlanta 34
Pune 34
Guangzhou 33
Washington 33
Amsterdam 31
Fairfield 31
Baghdad 30
Biên Hòa 28
Tashkent 28
Draper 27
Boston 26
Columbus 26
Phoenix 26
Ankara 25
Manchester 25
Belo Horizonte 24
Zhengzhou 24
Curitiba 21
Düsseldorf 21
Turin 21
Brasília 20
Dhaka 20
Hải Dương 20
Mumbai 20
Quito 20
Ningbo 19
Paris 19
Jinan 18
Piscataway 18
Secaucus 18
Brno 17
Totale 18.560
Salva come PNG Salva come JPEG
Nome #
Impaired respiratory function reduces haemoglobin oxygen affinity in COVID-19 339
Hepatitis B virus genotype distribution in HIV-1 coinfected patients 256
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 173
AGGRESSIVE INTERFERON THERAPY IN HIV-HCV COINFECTED PATIENTS 171
A mid-term follow-up with a lung ultrasonographic score correlates with the severity of COVID-19 acute phase 161
Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy 160
Subcutaneous 'lipoma-like' B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT. 155
Aggressive daily interferon therapy in HIV-HCV coinfected patients 153
Correction to: Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy (Internal and Emergency Medicine, (2020), 15, 8, (1457-1465), 10.1007/s11739-020-02493-y) 153
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 150
Distinct mutational drug resistance profiles of HIV-1 RNA in plasma in culture isolates of patients receiving antiretroviral theraphy 149
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 149
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 139
Nutritional parameters associated with prognosis in non-critically ill hospitalized COVID-19 patients: The NUTRI-COVID19 study 139
Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy 137
The Pavia consensus statement 135
Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020 134
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 133
Hospitalizations Associated With Mental Health Conditions Among Adolescents in the US and France During the COVID-19 Pandemic 132
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count 129
Daptomycin Pharmacokinetics and Pharmacodynamics in Patients on Methadone Substitution Therapy 127
Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation—a position paper 126
Mice and rabbits: Animal models for HIV-1 infection 125
Economic evaluation of HIV treatments: The I.CO.N.A. cohort study 125
Emergency Department and Out-of-Hospital Emergency System (112—AREU 118) integrated response to Coronavirus Disease 2019 in a Northern Italy centre 125
Consensus conference on TIPS management: Techniques, indications, contraindications 123
Host factors affecting the outcome of treatment of hepatitis C 122
Acute liver failure during lamivudine tratment in a hepatitis B cirrhotic patient 122
Mid-term follow-up chest CT findings in recovered COVID-19 patients with residual symptoms 119
Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection. 119
[New trends in the therapy of cryptococcosis in AIDS patients] 119
COVID vaccination and asthma exacerbation: might there be a link? 119
Fungal Osteomyelitis: A Systematic Review of Reported Cases 118
Tocilizumab for treatment of severe covid-19 patients: Preliminary results from smatteo covid19 registry (smacore) 118
Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospital 118
Forecast model for the evaluation of economic resources employed in the health care of patients with HIV infection. 117
Bayesian models identify specific lymphoproliferative disorders associated with hepatitis C virus infection 117
Coarse vs. fine needle aspiration biopsy for the assessment of diffuse liver disease from hepatitis C virus-related chronic hepatitis. 116
Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis 116
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 116
Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020 115
Emerging biological agents for hepatitis C 114
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 114
Lopinavir/ritonavir and darunavir/cobicistat in hospitalized covid-19 patients: Findings from the multicenter italian corist study 114
AISF position paper on liver disease and pregnancy 113
Acute arterial and deep venous thromboembolism in COVID-19 patients: Risk factors and personalized therapy 113
Ventilator-Associated Pneumonia Due to MRSA vs. MSSA: What Should Guide Empiric Therapy? 112
Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C. 112
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 111
Antiretroviral therapy in chronic liver disease: focus on HIV/HCV coinfection--statements of the First Italian Consensus Workshop 111
Challenges for hepatitis C patients coinfected with HIV. 111
A case of leprosy in a nonendemic country 111
Viral tropism by geno2pheno as a tool for predicting CD4 decrease in HIV-1-infected naive patients with high CD4 counts. 108
Daily Interferon therapy in HIV-HCV coinfected patients: Preliminary Report 108
A clinical case of sepsis due to staphylococcus pettenkoferi 108
Understanding the Mechanisms of Fibrogenesis in HIV/HCV-Coinfected Patients: Implications for Clinical Practice 107
Epidemiological characteristics of bloodstream infections in patients with different degrees of liver disease 107
Direct-acting Antivirals during or after Immuno-chemotherapy in Hepatitis C Virus-positive Diffuse Large B-cell Lymphomas 107
Plasma from donors recovered from the new Coronavirus 2019 as therapy for critical patients with COVID-19 (COVID-19 plasma study): a multicentre study protocol 107
Patients with chronic hepatitis C receiving treatment with direct acting antivirals: How is this population changing? 107
Lung ultrasound presentation of COVID-19 patients: phenotypes and correlations 106
High Frequencies of Functional Virus-Specific CD4+ T Cells in SARS-CoV-2 Subjects With Olfactory and Taste Disorders 106
Clinical phenotypes and outcomes in children with multisystem inflammatory syndrome across SARS-CoV-2 variant eras: a multinational study from the 4CE consortium 105
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study 105
Long-term kidney function recovery and mortality after COVID-19-associated acute kidney injury: an international multi-centre observational cohort study 104
Management of hepatitis C in human immunodeficiency virus-infected patients 104
Dissociation between serum and liver hepatitis C virus RNA levels in patients coinfected with human immunodeficiency virus 104
Rapid response to COVID-19 outbreak in Northern Italy: how to convert a classic infectious disease ward into a COVID-19 response centre 104
Dynamic NLR and PLR in Predicting COVID-19 Severity: A Retrospective Cohort Study 103
Characterization of long COVID temporal sub-phenotypes by distributed representation learning from electronic health record data: a cohort study 103
Transfusion-transmitted virus infection in HIV-1-seropositive patients 103
General issues on microbial translocation in HIV-infected patients 103
Cutaneous septic emboli from Candida glabrata in a haematological patient 103
Management of infections pre- and post-liver transplantation: report of an AISF consensus conference. 101
HCV-VIRAL KINETICS IN DIFFERENT CATEGORIES OF PATIENTS: DAILY VERSUS BID INDUCTION INTERFERON THERAPY 101
Comments on the review 'Care of patients with hepatitis C and HIV co-infection' by Soriano et al. 101
Ultrasound in the diagnosis of gallbladder ascariasis 100
Specificity and sensitivity of 3rd generation EIA for detection of HCV antibodies among intravenous drug-users 100
An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim Project 100
Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection: A case control study 100
Genetic heterogeneity of hepatitis C virus (HCV) in clinical strains of HIV positive and HIV negative patients chronically infected with HCV genotype 3a 98
Hepatotoxicity and nelfinavir: a meta-analysis 98
Expression of biomarkers of interferon type I in patients suffering from chronic diseases 98
Modelling liver fibrosis progression in chronic hepatitis C: a study of 563 patients with sequential liver biopsies 98
Spatial and temporal dynamics of hepatitis B virus d genotype in europe and the mediterranean basin. 98
The role of the rs12979860 polymorphism of the interleukin-28b as a predictor of sustained virological response after antiviral therapy in patients with hemophilia and chronic hepatitis C 98
Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects 98
Rapid hepatitis B virus-DNA decay in co-infected HIV-hepatitis B virus 'eminus' patients with YMDD mutations after 4 weeks of tenofovir therapy 98
Prioritization of high-cost new drugs for HCV: making sustainability ethical 98
Overview on the incidence and the characteristics of HIV-related opportunistic infections and neoplasms of the heart: impact of highly active antiretroviral therapy 97
Area-under-the-curve for peginterferon alpha-2a and peginterferon alpha-2b is not related to body weight in treatment-naive patients with chronic hepatitis C 97
Regression of indolent B-cell lymphoma after Lamivudine prophylaxis of hepatitis B virus infection. 97
Treatment of echinococcal abdominal cysts 96
Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection 96
Management of hepatitis C positive patients undergoing active treatment for malignancies: a position paper from the Associazione Italiana di Oncologia Medica (AIOM) and the Società Italiana di Malattie Infettive e Tropicali (SIMIT) 96
Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy 96
An eight-year experience of Nocardia infection in Italy: does immunosuppression matter? 95
The early phase of the COVID-19 epidemic in Lombardy, Italy 95
Management of hepatocellular carcinoma in human immunodeficiency virus-infected patients. 95
Effect of the IL-6 C174G gene polymorphism on treatment of acute and chronic hepatitis C in HIV co-infected patients 95
Totale 11.857
Salva come PNG Salva come JPEG
Categoria #
all - tutte 133.035
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 133.035
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202149 0 0 0 0 0 0 0 0 0 0 0 49
2021/20221.112 34 14 22 11 28 30 23 73 76 18 151 632
2022/20233.645 386 248 40 286 323 368 7 192 1.541 49 145 60
2023/20241.725 173 271 73 88 222 378 91 130 13 64 74 148
2024/20255.349 111 349 103 179 82 238 472 362 1.279 279 599 1.296
2025/202612.881 934 953 1.343 1.468 1.479 548 2.368 557 1.088 990 734 419
Totale 29.882